Complex reasons why antibacterials prescribed for sore throat Newsletter Article 17 February 2013 Pages: 2 - 2
Lipid-lowering drug use must be based on evidence of cost effectiveness Carlene Todd Newsletter Article 17 February 2013 Pages: 3 - 4
Is health economics useful to UK purchasers and providers? Newsletter Article 17 February 2013 Pages: 4 - 4
Problem of bacterial resistance clear - now it’s time to solve it Newsletter Article 17 February 2013 Pages: 4 - 5
Target dornase alfa therapy in adults with cystic fibrosis Newsletter Article 17 February 2013 Pages: 5 - 5
DTCA’s diabetes programme promising after less than 1 year Newsletter Article 17 February 2013 Pages: 6 - 6
Health plans wise to fully cover smoking-cessation programmes Newsletter Article 17 February 2013 Pages: 6 - 6
Nortriptyline a cost-effective alternative in major depression Newsletter Article 17 February 2013 Pages: 7 - 7
Rotavirus vaccination could save millions in Finland Newsletter Article 17 February 2013 Pages: 8 - 8
RSVIG prophylaxis cost exceeds avoided hospital charges Newsletter Article 17 February 2013 Pages: 8 - 8
Anticoagulation clinic proves its clinical and financial worth Newsletter Article 17 February 2013 Pages: 9 - 9
Cut hospital use in the elderly, spend savings more wisely? Newsletter Article 17 February 2013 Pages: 9 - 9
Fluticasone benefits children with asthma, and parents too? Newsletter Article 17 February 2013 Pages: 10 - 10
Clozapine plus psychosocial treatment helps in schizophrenia Newsletter Article 17 February 2013 Pages: 10 - 10